Search
Help, My Business is In Trouble! When a business becomes financially troubled, the business owner often experiences denial, paralysis, or both. Lenders commonly lose confidence and then trust in the business, as communications tend to break down, deadlines are missed, and promises are broken. Small...
Developing a Corporate AI Policy Join Association of Corporate Counsel, along with inside and outside counsel presenters, as they discuss implementing best practices and responsible use policies to manage the risk of utilizing AI in the workplace. Speakers: Matthew Kohel, Partner, Intellectual...
Since Elon Musk announced his decision to remove the iconic bird logo and adopt "X", as Twitter's new logo (the "X Logo"), the rebranding decision has been the talk of the town. The rollout has prompted a barrage of reactions and has many questioning whether the change will attract legal hurdles...
The TMA Restructuring Boot Camp is an interactive, two-part program taught by TMA Certified Turnaround Professionals (CTPs) and attorneys. The TMA Restructuring Boot Camp is a high-level overview of what it's like to parachute into a simulated distressed company to uncover the financial, management...
A recently filed class action lawsuit raises more legal challenges to providers of generative artificial intelligence (AI) tools that are used to create content. The suit cautions that a doomsday scenario is approaching and alleges a host of privacy and other violations occurring along the way. What...
Saul Ewing LLP, a full-service national law firm, is proud to announce that Bankruptcy & Restructuring Practice Vice Chair Monique B. DiSabatino was selected as one of Law360's 2023 Rising Stars. Editors reviewed more than 1,300 submissions for the Rising Star distinction, which recognizes top...
On May 18, 2023, the Supreme Court unanimously affirmed the Federal Circuit's decision, Amgen Inc. v. Sanofi, 987 F.3d 1080 (Fed. Cir. 2021), that the claims of two of Amgen's patents were invalid for lack enablement. The involved patents, US 8,829,165 and US 8,859,741, are directed to monoclonal...
Decision Time: Second Circuit Allows Controversial Nonconsensual Third-Party Releases in Purdue Pharma Chapter 11 Plan Join a distinguished panel of lawyers and law professors as they discuss the Second Circuit’s important Purdue Pharma decision. Whether you want to learn more about the circuit’s...
Charles M. Lizza and Sarah A. Sullivan of Saul Ewing’s Newark Office secured a precedent-setting victory in a patent infringement case in the Federal District Court for the District of New Jersey involving Janssen Pharmaceuticals, Inc.’s (“J&J”) and Mitsubishi Tanabe Pharma Corp.’s (“MTPC”)...
Drawing on our deep experience in higher education law, Saul Ewing attorneys assist for-profit educational institutions with their regulatory and operational needs. Our practice focuses on compliance and risk management. We help proprietary schools navigate the complex regulatory landscape; maintain...
When allegations of research fraud or misconduct come to light, the stakes for companies and research institutions could not be higher. Actions such as fabrication of scientific data, manipulation of research materials, and plagiarism can result in damaged reputations, loss of federal funding, and...
Edward (Ted) Behm brings more than 20 years of experience as an intellectual property attorney to his work assisting clients with patent preparation and prosecution and IP litigation. His patent preparation and prosecution work includes both domestic and foreign patents, trademarks and copyrights...